Journal of Alzheimer s Disease · 2015 · 81 citations · 38 references
MedicineNeurologyNeuroscienceCognitive NeurologyCognitive NeuroscienceDementiaAlzheimer DiseaseBrain ImagingCognitive ImpairmentFunctional NeuroimagingNeurodegenerative DiseasesPositron Emission TomographyAlzheimer's Disease DiagnosisAmnestic ImpairmentCognitive BiomarkersGlucose Metabolism ImagingMild Cognitive Impairment DiagnosisMild Cognitive Impairment ImagingNeuroimaging MarkersNeuroimaging Of Cognitive Impairment
We aimed to investigate the accuracy of FDG-PET to detect the Alzheimer's disease (AD) brain glucose hypometabolic pattern in 142 patients with amnestic mild cognitive impairment (aMCI) and 109 healthy controls. aMCI patients were followed for at least two years or until conversion to dementia. Images were evaluated by means of visual read by either moderately-skilled or expert readers, and by means of a summary metric of AD-like hypometabolism (PALZ score). Seventy-seven patients converted to AD-dementia after 28.6 ± 19.3 months of follow-up. Expert reading was the most accurate tool to detect these MCI converters from healthy controls (sensitivity 89.6%, specificity 89.0%, accuracy 89.2%) while two moderately-skilled readers were less (p < 0.05) specific (sensitivity 85.7%, specificity 79.8%, accuracy 82.3%) and PALZ score was less (p < 0.001) sensitive (sensitivity 62.3%, specificity 91.7%, accuracy 79.6%). Among the remaining 67 aMCI patients, 50 were confirmed as aMCI after an average of 42.3 months, 12 developed other dementia, and 3 reverted to normalcy. In 30/50 persistent MCI patients, the expert recognized the AD hypometabolic pattern. In 13/50 aMCI, both the expert and PALZ score were negative while in 7/50, only the PALZ score was positive due to sparse hypometabolic clusters mainly in frontal lobes. Visual FDG-PET reads by an expert is the most accurate method but an automated, validated system may be particularly helpful to moderately-skilled readers because of high specificity, and should be mandatory when even a moderately-skilled reader is unavailable.
38
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack, David S. Knopman, William J. Jagust et al. · The Lancet Neurology · 2009 · 4.8K citations · Full text
The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods
Clifford R. Jack, Matt A. Bernstein, Nick C. Fox et al. · Journal of Magnetic Resonance Imaging · 2008 · 4.4K citations · Full text
Medicine, Neurology, Neuroscience +17